Shanghai Pharmaceuticals (02607) Releases October 2025 Monthly Return Announcement

Bulletin Express11-03

Shanghai Pharmaceuticals Holding Co., Ltd. (stock code: 02607) published its monthly return for equity issuer for the period ended 31 October 2025. According to the announcement, the total authorized share capital remained at RMB 3,708,361,809 during the reporting period, comprising 919,072,704 H shares and 2,789,289,105 A shares, both with a par value of RMB 1 each.

The issued share capital also remained unchanged, with 919,072,704 H shares listed in Hong Kong and 2,789,289,105 A shares (stock code: 601607) unlisted in Hong Kong. No additional shares were issued, and no treasury shares were created or cancelled. In the share option segment, 680,000 A-share options at an exercise price of RMB 20.16 remained outstanding, with no options exercised during the month.

Overall, there were no changes to the company’s authorized share capital, issued share capital, or treasury shares during October 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1136549663?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-03 23:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136549663","market":"us","top_or_hot":-1,"title":"Shanghai Pharmaceuticals (02607) Releases October 2025 Monthly Return Announcement","media":"Bulletin Express","content":"<p>Shanghai Pharmaceuticals Holding Co., Ltd. (stock code: 02607) published its monthly return for equity issuer for the period ended 31 October 2025. According to the announcement, the total authorized share capital remained at RMB 3,708,361,809 during the reporting period, comprising 919,072,704 H shares and 2,789,289,105 A shares, both with a par value of RMB 1 each.</p>\n<p>The issued share capital also remained unchanged, with 919,072,704 H shares listed in Hong Kong and 2,789,289,105 A shares (stock code: 601607) unlisted in Hong Kong. No additional shares were issued, and no treasury shares were created or cancelled. In the share option segment, 680,000 A-share options at an exercise price of RMB 20.16 remained outstanding, with no options exercised during the month.</p>\n<p>Overall, there were no changes to the company’s authorized share capital, issued share capital, or treasury shares during October 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Pharmaceuticals (02607) Releases October 2025 Monthly Return Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Pharmaceuticals (02607) Releases October 2025 Monthly Return Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-03 23:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Pharmaceuticals Holding Co., Ltd. (stock code: 02607) published its monthly return for equity issuer for the period ended 31 October 2025. According to the announcement, the total authorized share capital remained at RMB 3,708,361,809 during the reporting period, comprising 919,072,704 H shares and 2,789,289,105 A shares, both with a par value of RMB 1 each.</p>\n<p>The issued share capital also remained unchanged, with 919,072,704 H shares listed in Hong Kong and 2,789,289,105 A shares (stock code: 601607) unlisted in Hong Kong. No additional shares were issued, and no treasury shares were created or cancelled. In the share option segment, 680,000 A-share options at an exercise price of RMB 20.16 remained outstanding, with no options exercised during the month.</p>\n<p>Overall, there were no changes to the company’s authorized share capital, issued share capital, or treasury shares during October 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02607","symbol_name":"上海医药","start_time":0,"source_url":"","article_id":"1136549663","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136549663","pubTimestamp":1762183446,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Pharmaceuticals Holding Co., Ltd. (stock code: 02607) published its monthly return for equity issuer for the period ended 31 October 2025. According to the announcement, the total authorized...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02607":"上海医药"},"translate_title":"上海医药(02607)发布2025年10月月报表公告","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co., Ltd. (stock code: 02607) published its monthly return for equity issuer for the period ended 31 October 2025. According to the announcement, the total authorized share capital remained at RMB 3,708,361,809 during the reporting period, comprising 919,072,704 H shares and 2,789,289,105 A shares, both with a par value of RMB 1 each.\nThe issued share capital also remained unchanged, with 919,072,704 H shares listed in Hong Kong and 2,789,289,105 A shares (stock code: 601607) unlisted in Hong Kong. No additional shares were issued, and no treasury shares were created or cancelled. In the share option segment, 680,000 A-share options at an exercise price of RMB 20.16 remained outstanding, with no options exercised during the month.\nOverall, there were no changes to the company’s authorized share capital, issued share capital, or treasury shares during October 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1136549663","isCrawlerRequest":true}